← Leaderboards
Michael Henderson
Yale University
$2,648,992
Attributed
$2,998,604
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $913.3K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,998,604 · 4
By mechanism
R01$1,808,647 · 1
R43$699,225 · 1
R21$446,020 · 1
F31$44,712 · 1
Top collaborators
- Bahareh Behrouz2 shared
Most similar at Yale University
Same institution · by research overlap
- Sreeganga S Chandra$8,282,350
- Naftali Kaminski$42,947,928
- Nelli Mnatsakanyan$4,481,445
- Alexandra Elizabeth Maccoll Garfinkel$108,760
- Richard P Lifton$24,984,883
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuronsS DiseaseBrainAffectNerve DegenerationDisease ProgressionPathologyCellsComplexAlpha SynucleinNeurodegenerative DisordersAnimal ModelProteinsPersonsInsightTau ProteinsDementiaPathologicMolecularProtein AggregationAnatomyAmyloid Beta-ProteinDementia With Lewy Bodies
Grant awards (9)
Network and cellular vulnerability to pathological protein progression$432,333
R01 · FY2025 · AG · contact PI
Network and cellular vulnerability to pathological protein progression$441,969
R01 · FY2024 · AG · contact PI
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease$228,711
R43 · FY2024 · NS
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease$470,514
R43 · FY2023 · NS
Network and cellular vulnerability to pathological protein progression$442,759
R01 · FY2023 · AG · contact PI
Network and cellular vulnerability to pathological protein progression$491,586
R01 · FY2022 · AG · contact PI
Investigating the role of MARKs in Parkinson's disease pathogenesis$446,020
R21 · FY2020 · NS · contact PI
CSP alpha regulation of exo-endocytic cycle enhances synaptic stability$17,468
F31 · FY2013 · NS · contact PI
CSP alpha regulation of exo-endocytic cycle enhances synaptic stability$27,244
F31 · FY2012 · NS · contact PI